You just read:

Neurologists Anticipate Overall Expansion of the Fumarate Class Following the US Launch of Biogen's Vumerity for Treatment in Multiple Sclerosis, According to Spherix Global Insights

News provided by

Spherix Global Insights

Dec 10, 2019, 08:00 ET